1 Min Read
Aug 24 (Reuters) - Titan Pharmaceuticals Inc
* Titan Pharmaceuticals receives fda clearance to begin clinical study of Parkinson’s disease treatment Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.